Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.32 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.32 |
| ▸ | PSMB8 | P28062 | 2/20 | 0.31 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25819837 | 0.87 | MGLL (0.31) | PSMB8PSMB5 | |
| SCHEMBL2607876 | 0.85 | ADORA3 (0.37) | ALDH1A1ADORA3ADORA2AADORA2BKMT2A | |
| SCHEMBL12015106 | 0.84 | PSMB8 (0.32) | ADORA3ADORA2AADORA2BPSMB8PSMB5 | |
| SCHEMBL10057853 | 0.83 | PSMB8 (0.33) | ALDH1A1ADORA3ADORA2AADORA2BPSMB8 | |
| SCHEMBL12138348 | 0.83 | — | — | |
| SCHEMBL29713990 | 0.83 | PSMB8 (0.31) | PSMB8PSMB5 | |
| SCHEMBL2263421 | 0.83 | MGLL (0.35) | PSMB8PSMB5 | |
| Ether SCHEMBL7956358 | 0.83 | TSHR (0.42) | ALDH1A1PSMB8PSMB5KMT2ASMN1; SMN2 | |
| SCHEMBL14110324 | 0.82 | MGLL (0.31) | PSMB8PSMB5 | |
| SCHEMBL277616 | 0.82 | ALDH1A1 (0.33) | ALDH1A1ADORA3ADORA2AADORA2BPSMB8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230226219-A1 | PEG LIPIDOID COMPOUNDS | TRANSLATE BIO, INC. | 2023-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230226219-A1 | PEG LIPIDOID COMPOUNDS | LIPG, ABCB4, HDLBP | ALDH1A1 3688/4885ADORA3 4645/4885ADORA2A 4539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.